Synthesis of NG-monomethylagmatine, a decarboxylation product of NG-monomethyl-l-arginine
✍ Scribed by Yung-Bong Cho; Kwang Sook Park; Sangduk Kim; Woon Ki Paik
- Publisher
- Elsevier Science
- Year
- 1987
- Tongue
- English
- Weight
- 344 KB
- Volume
- 160
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
✦ Synopsis
NG-Monomethylagmatine, a decarboxylation product of NG-monomethyl-L-arginine, has been synthesized by reacting putrescine with N,S-dimethylthiopseudouronium iodide. The structural identity of the product was confirmed by proton NMR and mass spectroscopy, and its properties were determined on thin-layer and electrophoretic chromatography.
📜 SIMILAR VOLUMES
## Abstract N^G^‐Mono[^14^C‐methyl]‐L‐arginine was prepared in a two‐step synthesis. N,S‐dimethylthiopseudouronium iodide [methyl‐^14^C] was prepared in excellent yield and afforded the labelled amino acid on coupling with L‐ornithine.
As we have previously reported, intraperitoneal injections of NG-nitro-L-arginine methyl ester [L-NAME; a competitive inhibitor of nitric oxide (NO) synthase] before and after the injection of B16 melanoma cells through a tail vein increased experimental pulmonary metastasis, while simultaneous inje
## Abstract **BACKGROUND:** To test whether the differentiating embryo is susceptible to the teratogenic effects of the nitric oxide (NO) synthesis inhibitor N^G^‐nitro‐L‐arginine methyl ester (L‐NAME). **METHODS:** ICR‐(CD‐1) mice received a single intraperitoneal injection of L‐NAME at 90, 150, o
Enhanced pulmonary production of nitric oxide (NO) has been implicated in the pathogenesis of hepatopulmonary syndrome (HPS). NO inhibition with N(G)-nitro-L-arginine methyl ester (L-NAME) in both animals and humans with HPS has improved arterial hypoxemia. We assessed the role of enhanced NO produc